Association of rs613872 and Trinucleotide Repeat Expansion in the TCF4 Gene of German Patients With Fuchs Endothelial Corneal Dystrophy.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 12 4 2019
medline: 27 6 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

To investigate single nucleotide polymorphisms (SNPs) and trinucleotide repeat (TNR) expansion in the transcription factor 4 (TCF4) gene in a large cohort of German patients with Fuchs endothelial corneal dystrophy (FECD). Genomic DNA was obtained from 398 patients with FECD and from 58 non-FECD controls. Thirty-seven previously reported SNPs were evaluated by genotyping. The 398 FECD samples were analyzed for TNR expansions by short tandem repeat assays and Southern blotting. The possible associations between the TNR length and clinical parameters (age, sex, visual acuity, and central corneal thickness) were analyzed in 132 patients. The SNPs in COL8A2, TCF8, LOXHD1, and AGBL1 showed no heterogeneity in 36 cases, although SLCA411 showed 3 nonsense mutations. SNPs were detected for TCF4 (rs613872, rs2123392, rs17089887, rs1452787, and rs1348047), but only rs613872 showed a significant association with FECD (P = 9.93 × 10). Overall, 315/398 (79%) patients harbored TNR lengths >50, whereas no non-FECD controls harbored TNR lengths >50. The TCF4 SNP rs613872 genotype was TT: 39 (67%), TG: 18 (31%), and GG: 1 (2%) in non-FECD controls; TT: 39 (47%), TG: 38 (46%), and GG: 6 (7%) in FECD cases harboring TNR <50; and TT: 23 (8%), TG: 224 (79%), and GG: 38 (13%) in FECD cases harboring TNR >50 (P = 2.93 × 10). No significant association was detected between the TNR length and clinical parameters. Our large German cohort demonstrated a significant association between the risk allele G in rs613872 and FECD, irrespective of TNR expansion, although this risk allele was more frequent in FECD cases with TNR expansion than without.

Identifiants

pubmed: 30973406
doi: 10.1097/ICO.0000000000001952
pmc: PMC6554040
mid: NIHMS1523040
doi:

Substances chimiques

TCF4 protein, human 0
Transcription Factor 4 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-805

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026490
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY025071
Pays : United States

Références

Hum Mol Genet. 2001 Oct 1;10(21):2415-23
pubmed: 11689488
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):140-5
pubmed: 16384955
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3919-26
pubmed: 16936105
Hum Mol Genet. 2008 Mar 1;17(5):656-66
pubmed: 18024964
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):184-8
pubmed: 18172091
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5667-71
pubmed: 19608540
Am J Hum Genet. 2010 Jan;86(1):45-53
pubmed: 20036349
N Engl J Med. 2010 Sep 9;363(11):1016-24
pubmed: 20825314
Hum Mutat. 2010 Nov;31(11):1261-8
pubmed: 20848555
PLoS One. 2011 Apr 20;6(4):e18044
pubmed: 21533127
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5573-8
pubmed: 21659310
Am J Hum Genet. 2012 Mar 9;90(3):533-9
pubmed: 22341973
PLoS One. 2012;7(11):e49083
pubmed: 23185296
Clin Genet. 2013 Aug;84(2):109-19
pubmed: 23662738
Ophthalmic Genet. 2014 Sep;35(3):138-41
pubmed: 23758498
Am J Hum Genet. 2013 Oct 3;93(4):758-64
pubmed: 24094747
Invest Ophthalmol Vis Sci. 2014 Jan 02;55(1):33-42
pubmed: 24255041
Invest Ophthalmol Vis Sci. 2014 Oct 08;55(11):7073-8
pubmed: 25298419
Invest Ophthalmol Vis Sci. 2014 Oct 23;55(11):7674-80
pubmed: 25342617
J Biol Chem. 2015 Mar 6;290(10):5979-90
pubmed: 25593321
Invest Ophthalmol Vis Sci. 2015 Feb 26;56(3):2003-11
pubmed: 25722209
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4531-6
pubmed: 26200491
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4865-9
pubmed: 26218914
Klin Monbl Augenheilkd. 2016 Feb;233(2):187-94
pubmed: 26280645
Prog Mol Biol Transl Sci. 2015;134:79-97
pubmed: 26310151
Biomed Res Int. 2015;2015:640234
pubmed: 26451375
Nat Commun. 2017 Mar 30;8:14898
pubmed: 28358029
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1621-1631
pubmed: 28608272
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6046-6049
pubmed: 29196769
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1888-1896
pubmed: 29677349
Arch Ophthalmol. 1978 Nov;96(11):2036-9
pubmed: 309758

Auteurs

Naoki Okumura (N)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Ryousuke Hayashi (R)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Masakazu Nakano (M)

Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Kei Tashiro (K)

Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Kengo Yoshii (K)

Department of Mathematics and Statistics in Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Ross Aleff (R)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.

Malinda Butz (M)

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Edward W Highsmith (EW)

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Eric D Wieben (ED)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.

Michael P Fautsch (MP)

Ophthalmology, Mayo Clinic, Rochester, MN.

Keith H Baratz (KH)

Ophthalmology, Mayo Clinic, Rochester, MN.

Yuya Komori (Y)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Emi Ueda (E)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Makiko Nakahara (M)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Julia Weller (J)

Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.

Theofilos Tourtas (T)

Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.

Ursula Schlötzer-Schrehardt (U)

Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.

Friedrich Kruse (F)

Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.

Noriko Koizumi (N)

Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH